Current Investment


APONTIS is a leading German supplier of pharmaceuticals for chronically ill patients. Next to co-marketing activities, the company focuses on the development and promotion of single pills and has established itself as a pioneer in this segment. Single pills are a combination of two to three ingredients in one single pill, which has proven to significantly increase adherence and thus patient prognoses compared to the conventional therapy with 2-3 separate pills. APONTIS strong, experienced sales force has direct access to over 24,000 general practitioners in Germany. APONTIS is headquartered in Monheim and employs around 200 people.